TCS ADDTata Consultancy Services
|
TrialMindKeiji AI, Inc.
|
|||||
Related Products
|
||||||
About
TCS ADD platform accelerates speed-to-market for pharmaceutical industry across the entire clinical R&D value chain and helps make clinical trials more agile and safe. TCS ADD enables digital ecosystems, simplifies data complexity and provides faster access to new and effective drugs for the patients. The platform is powered by cognitive artificial intelligence engine called TCS Decision FabricTM, smart analytics and IoT that provides superior business value to pharmaceutical industry. A next-generation and end-to-end metadata-driven solution to manage industry & sponsor clinical standards. A data science-driven platform that leverages AI & ML technologies to enable quicker decisions, faster study start-up and targeted interventions. A solution that digitizes the entire clinical trial supply management process while putting the patient in the center, increasing patient’s safety and overall efficacy.
|
About
TrialMind is a clinical research AI platform for pharmaceutical and biotechnology companies, contract research organizations, and academic medical centers. Its agents support trial design, statistical programming, real-world evidence, cohort analysis, literature review, clinical-trial landscape research, and clinical operations. Workflows include site selection, patient-to-trial matching, eligibility refinement, enrollment and dropout forecasts, and data and medical monitoring. Teams can describe tasks in natural language, review analysis plans, and inspect results with linked sources, methods, and code. TrialMind is offered as hosted software, private cloud, or deployment in a customer's environment. Raw patient records are not moved out of the customer's environment during matching. API and Model Context Protocol access support embedding its tools in other platforms.
|
|||||
Platforms Supported
Windows
Not Supported
Mac
Not Supported
Linux
Not Supported
Cloud
Not Supported
On-Premises
Not Supported
iPhone
Not Supported
iPad
Not Supported
Android
Not Supported
Chromebook
Not Supported
|
Platforms Supported
Windows
Not Supported
Mac
Not Supported
Linux
Not Supported
Cloud
Supported
On-Premises
Not Supported
iPhone
Not Supported
iPad
Not Supported
Android
Not Supported
Chromebook
Not Supported
|
|||||
Audience
Scientists, healthcare industries and laboratories in need of a platform for drug development in life sciences
|
Audience
Sponsors, CROs, and academic medical centers
|
|||||
Support
Phone Support
Supported
24/7 Live Support
Not Supported
Online
Supported
|
Support
Phone Support
Supported
24/7 Live Support
Not Supported
Online
Not Supported
|
|||||
API
Offers API
Not Supported
|
API
Offers API
Supported
|
|||||
Screenshots and Videos |
Screenshots and Videos |
|||||
Pricing
No information available.
Free Version
Not Supported
Free Trial
Supported
|
Pricing
$500/user/month
$500 per user per month.
Free Version
Not Supported
Free Trial
Not Supported
|
|||||
Reviews/
|
Reviews/
|
|||||
Training
Documentation
Supported
Webinars
Supported
Live Online
Not Supported
In Person
Supported
|
Training
Documentation
Supported
Webinars
Supported
Live Online
Supported
In Person
Not Supported
|
|||||
Company InformationTata Consultancy Services
Founded: 1968
India
www.tcs.com/tcs-add
|
Company InformationKeiji AI, Inc.
Founded: 2023
United States
keiji.ai
|
|||||
Alternatives |
Alternatives |
|||||
|
|
||||||
|
|
||||||
|
|
||||||
Categories |
Categories |
|||||
Integrations
AODocs
Supported
Adenza
Supported
Amazon Web Services (AWS)
Supported
Apigee
Supported
Appian
Supported
BeyondTrust Endpoint Privilege Management
Supported
Blueprint
Supported
CA Flowdock
Supported
Freshdesk
Supported
HPE Consumption Analytics
Supported
|
Integrations
AODocs
Not Supported
Adenza
Not Supported
Amazon Web Services (AWS)
Not Supported
Apigee
Not Supported
Appian
Not Supported
BeyondTrust Endpoint Privilege Management
Not Supported
Blueprint
Not Supported
CA Flowdock
Not Supported
Freshdesk
Not Supported
HPE Consumption Analytics
Not Supported
|
|||||
|
|
|